博瑞医药：首次回购约5.59万股

Group 1 - Company announced a share buyback of approximately 55,900 shares, representing 0.0132% of its total share capital of about 423 million shares [1] - The buyback was conducted through the Shanghai Stock Exchange with a total expenditure of approximately 2.99 million RMB, with a maximum price of 54.28 RMB per share and a minimum price of 52.96 RMB per share [1] - For the year 2024, the company's revenue composition is 97.33% from pharmaceutical manufacturing and 2.67% from other businesses [1] Group 2 - The current market capitalization of the company is 22.6 billion RMB [2]